Showing results (1211-1220 of 1,333) with videos related to

Sort By:
Pageof 134
American Journal of Hematology|February 13, 2013
Velaglucerase alfa enzyme replacement therapy compared with imiglucerase in patients with Gaucher diseaseHadhami Ben Turkia, Derlis E Gonzalez, Norman W Barton, et al.
Pediatric Cardiology|November 30, 2012
The pediatric cardiology pharmacopeia: 2013 updatePaul Nicholas Severin, Sawsan Awad, Beth Shields, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
Fibroblast depletion reveals mammalian epithelial resilience across neonatal and adult stagesIsabella M Gaeta, Shuangshuang Du, Clémentine Villeneuve, et al.
Journal of Extracellular Biology|June 28, 2024
Extracellular vesicles released by steatotic hepatocytes alter adipocyte metabolismJ E Mleczko, F Royo, I Samuelson, et al.
The New England Journal of Medicine|December 14, 2022
Trial of Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis BullosaShireen V Guide, Mercedes E Gonzalez, I Sinem Bağcı, et al.
The Journal of Climate Change and Health|February 6, 2026
Assessing the impacts, risks, and vulnerabilities of extreme heat in learning environments of Puerto Rico in 2023Pablo A Méndez-Lázaro, Laura T Cabrera-Rivera, Digna Rueda-Roa, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 9, 2016
New clinical trials regulation in Spain: analysis of royal decree 1090/2015M Martin Jimenez, A Calvo Ferrandiz, J Aparicio Urtasun, et al.
Pathogens (Basel, Switzerland)|January 22, 2024
Antibody Banding Patterns on the Enzyme-Linked Immunoelectrotransfer Blot (EITB) Assay Clearly Discriminate Viable Cysticercosis in Naturally Infected PigsGianfranco Arroyo, Andres G Lescano, Cesar M Gavidia, et al.
Neurology|August 2, 2001
Proposed diagnostic criteria for neurocysticercosisO H Del Brutto, V Rajshekhar, A C White, et al.
Antimicrobial Agents and Chemotherapy|February 13, 2019
Pharmacokinetics, Safety, and Tolerability of Oxfendazole in Healthy Volunteers: a Randomized, Placebo-Controlled First-in-Human Single-Dose Escalation StudyGuohua An, Daryl J Murry, Kiran Gajurel, et al.
Pageof 134